Ignatenko, N.A.; Trinh, H.T.; Wagner, A.M.; Gerner, E.W.; Bime, C.; Hsu, C.-H.; Besselsen, D.G.
Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection. Viruses 2025, 17, 1306.
https://doi.org/10.3390/v17101306
AMA Style
Ignatenko NA, Trinh HT, Wagner AM, Gerner EW, Bime C, Hsu C-H, Besselsen DG.
Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection. Viruses. 2025; 17(10):1306.
https://doi.org/10.3390/v17101306
Chicago/Turabian Style
Ignatenko, Natalia A., Hien T. Trinh, April M. Wagner, Eugene W. Gerner, Christian Bime, Chiu-Hsieh Hsu, and David G. Besselsen.
2025. "Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection" Viruses 17, no. 10: 1306.
https://doi.org/10.3390/v17101306
APA Style
Ignatenko, N. A., Trinh, H. T., Wagner, A. M., Gerner, E. W., Bime, C., Hsu, C.-H., & Besselsen, D. G.
(2025). Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection. Viruses, 17(10), 1306.
https://doi.org/10.3390/v17101306